Peter Sandy
About Peter Sandy
Peter Sandy serves as the Director of Translational Medicine at Roivant Sciences in Boston, Massachusetts, where he has worked since 2021. With a strong background in oncology and inflammation, he has over a decade of experience in industrial drug discovery and has held various leadership roles in the field.
Current Role at Roivant Sciences
Peter Sandy serves as the Director of Translational Medicine at Roivant Sciences, a position he has held since 2021. Based in Boston, Massachusetts, he has contributed to the company's focus on innovative drug development. His role involves overseeing clinical biomarker data generation, which is crucial for advancing therapeutic strategies in the pharmaceutical industry.
Previous Experience in Translational Medicine
Before joining Roivant Sciences, Peter Sandy worked as the Director of Translational Medicine at Silicon Therapeutics for 10 months in 2020. He also held a similar position at Evelo Biosciences from 2015 to 2020, where he spent five years focusing on translational strategies in drug development. His extensive experience in these roles has equipped him with valuable insights into the complexities of clinical research.
Educational Background in Oncology and Biology
Peter Sandy earned his Ph.D. in Oncology and Cancer Biology from the University of Szeged, Hungary, where he studied from 1996 to 2001. Prior to this, he completed his B.Sc. in Biology and Chemistry at the same university from 1991 to 1996. This strong academic foundation has supported his career in the biomedical field.
Career in Drug Discovery and Research
With over a decade of experience in industrial drug discovery, Peter Sandy has specialized in oncology and inflammation. He previously worked as a Senior Scientist I at Constellation Pharmaceuticals from 2009 to 2015. Additionally, he served as a Postdoctoral Associate at MIT's Center for Cancer Research, where he contributed to significant research initiatives from 2003 to 2009.
Skills and Expertise
Peter Sandy possesses excellent organizational and communication skills, which are essential for his role in translational medicine. His proficiency in overseeing clinical biomarker data generation enhances his capability to drive research initiatives and collaborate effectively with cross-functional teams in the pharmaceutical sector.